Membrane-altering effects of velnacrine and N-methylacridinium: Relevance to tacrine and Alzheimer's disease
- 15 June 1992
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 185 (2) , 596-603
- https://doi.org/10.1016/0006-291x(92)91666-e
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Advances in Alzheimer's diseaseThe FASEB Journal, 1991
- Structure-activity investigation of the alteration of the physical state of the skeletal network of proteins in human erythrocyte membranes induced by 9-amino-1,2,3,4-tetrahydroacridineBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Heterogeneity of adverse hepatic reactions to tetrahydroaminoacridineAustralian and New Zealand Journal of Medicine, 1990
- Spin-Labelling Studies of the Interaction of 9-Amino-1,2,3,4-Tetrahydroacridine (Tha), A Proposed Drug for the Treatment of Alzheimer's Disease, with Erythrocyte MembranesFree Radical Research Communications, 1990
- Determination of tacrine and its 1-hydroxy metabolite in plasma using column liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Clinical Experience with and Side-effects of Tacrine Hydrochloride in Alzheimer's Disease: A Pilot StudyAge and Ageing, 1989
- Tacrine in the Treatment of Alzheimer’s DiseaseEuropean Neurology, 1989
- (.+-.)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicityJournal of Medicinal Chemistry, 1988
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982